Metastasis regulation by PPARD expression in cancer cells.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  JCI Insight

• Publication date

  2017-01-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/jci.insight.91419PMID 28097239PMCID PMC5214933
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Sucrose-Enriched Diet Promotes Tumorigenesis in Mammary Gland in Part through the 12-Lipoxygenase Pathway.

  2016cited by this paper
• Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting

  2015cited by this paper
• The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state

  2015cited by this paper
• Functional links between Snail-1 and Cx43 account for the recruitment of Cx43-positive cells into the invasive front of prostate cancer.

  2014cited by this paper
• Ligand-activated PPARδ modulates the migration and invasion of melanoma cells by regulating Snail expression.

  2014cited by this paper
• Role of SPARC in Bone Remodeling and Cancer‐Related Bone Metastasis

  2014cited by this paper
• STC1 expression is associated with tumor growth and metastasis in breast cancer

  2014cited by this paper
• PPARδ deficiency disrupts hypoxia‐mediated tumorigenic potential of colon cancer cells

  2014cited by this paper
• Potentiation of colon cancer susceptibility in mice by colonic epithelial PPAR-δ/β overexpression.

  2014cited by this paper
• Synuclein γ Compromises Spindle Assembly Checkpoint and Renders Resistance to Antimicrotubule Drugs

  2014cited by this paper
• Role of Peroxisome Proliferator-Activated Receptor β/δ and B-Cell Lymphoma-6 in Regulation of Genes Involved in Metastasis and Migration in Pancreatic Cancer Cells

  2013cited by this paper
• Regulatory networks defining EMT during cancer initiation and progression

  2013cited by this paper
• Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

  2013cited by this paper
• Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer

  2013cited by this paper
• PPARδ promotes oncogenic redirection of TGF-β1 signaling through the activation of the ABCA1-Cav1 pathway

  2013cited by this paper
• Targeting peroxisome proliferator-activated receptor-β/δ in colon cancer: how to aim?

  2013cited by this paper
• STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer.

  2013cited by this paper
• Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion

  2012cited by this paper
• The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

  2012cited by this paper
• Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients

  2012cited by this paper
• The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention

  2012cited by this paper
• Functional characterization of peroxisome proliferator‐activated receptor‐β/δ expression in colon cancer

  2011cited by this paper
• Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Biological Function and Prognostic Significance of Peroxisome Proliferator-Activated Receptor δ in Rectal Cancer

  2011cited by this paper
• The Emerging Role of the Thrombin Receptor (PAR-1) in Melanoma Metastasis - a Possible Therapeutic Target

  2011cited by this paper
• Unravelling the complexity of metastasis — molecular understanding and targeted therapies

  2011cited by this paper
• Vimentin in cancer and its potential as a molecular target for cancer therapy

  2011influential reference
• The diagnostic value of circulating stanniocalcin‐1 mRNA in non‐small cell lung cancer

  2011cited by this paper
• Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models

  2011cited by this paper
• The Reciprocal Regulation of γ-Synuclein and IGF-I Receptor Expression Creates a Circuit That Modulates IGF-I Signaling*

  2010cited by this paper
• Peroxisome Proliferator-activated Receptor δ Activators Induce IL-8 Expression in Nonstimulated Endothelial Cells in a Transcriptional and Posttranscriptional Manner*

  2010cited by this paper
• Impact of RNA degradation on gene expression profiling

  2010cited by this paper
• An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

  2010cited by this paper
• Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance.

  2010cited by this paper
• Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin.

  2010cited by this paper
• Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis.

  2009cited by this paper
• Tumor self-seeding by circulating cancer cells.

  2009cited by this paper
• A Prospective Study of Dietary Polyunsaturated Fatty Acids and Colorectal Cancer Risk in Chinese Women

  2009cited by this paper
• PrognoScan: a new database for meta-analysis of the prognostic value of genes

  2009cited by this paper
• Synuclein-γ Is Closely Involved in Perineural Invasion and Distant Metastasis in Mouse Models and Is a Novel Prognostic Factor in Pancreatic Cancer

  2009cited by this paper
• The Interleukin-8 Pathway in Cancer

  2008cited by this paper
• Modes of resistance to anti-angiogenic therapy

  2008cited by this paper
• Peroxisome proliferator-activated receptor beta/delta expression and activation in lung cancer.

  2008cited by this paper
• Pathways Mediating Resistance to Vascular Endothelial Growth Factor–Targeted Therapy

  2008cited by this paper
• Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.

  2008cited by this paper
• Transcriptional network governing the angiogenic switch in human pancreatic cancer

  2007influential reference
• γ‐Synuclein and the progression of cancer

  2007cited by this paper
• Deregulation of tumor angiogenesis and blockade of tumor growth in PPARβ‐deficient mice

  2007cited by this paper
• Gamma-synuclein and the progression of cancer.

  2007cited by this paper
• Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.

  2007cited by this paper
• Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands do not potentiate growth of human cancer cell lines

  2007cited by this paper
• Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer

  2007cited by this paper
• Metastasis: a question of life or death

  2006cited by this paper
• Crosstalk between peroxisome proliferator-activated receptor δ and VEGF stimulates cancer progression

  2006cited by this paper
• Differentiation of Trophoblast Giant Cells and Their Metabolic Functions Are Dependent on Peroxisome Proliferator-Activated Receptor β/δ

  2006cited by this paper
• Expression of PPARδ in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology

  2006cited by this paper
• Genes that mediate breast cancer metastasis to lung

  2005cited by this paper
• Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers.

  2005cited by this paper
• Modeling metastasis in vivo.

  2004cited by this paper
• Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis.

  2004cited by this paper
• SPARC and tumor growth: Where the seed meets the soil?

  2004cited by this paper
• Peroxisome proliferator–activated receptor-δ attenuates colon carcinogenesis

  2004cited by this paper
• Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell lines.

  2004cited by this paper
• Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4.

  2003cited by this paper
• The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

  2003cited by this paper
• Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model

  2003cited by this paper
• Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer.

  2002cited by this paper
• Connexin 43, but not connexin 32, is mutated at advanced stages of human sporadic colon cancer

  2002cited by this paper
• Role of angiogenesis in tumor growth and metastasis.

  2002cited by this paper
• Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer Cells*

  2002cited by this paper
• Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer

  2001cited by this paper
• Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells.

  2001cited by this paper
• Genetic disruption of PPARδ decreases the tumorigenicity of human colon cancer cells

  2001cited by this paper
• Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer.

  2000cited by this paper
• PPAR d Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs

  1999cited by this paper
• PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs.

  1999cited by this paper
• Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.

  1992cited by this paper

• PPARδ: An Underappreciated Tumor Accelerator in Pancreatic Ductal Adenocarcinoma.

  2026cites this paper
• The Emerging Role of Peroxisome Proliferator-Activated Receptors in Cancer Stemness

  2025influential citation
• Erucic Acid, Derived by Lactobacillus Crispatus, Induces Ferroptosis in Cervical Cancer Organoids Through the PPAR‐δ Signaling Pathway

  2025cites this paper
• TPL2 Promotes Gastric Cancer Progression and Chemoresistance Through a Hypoxia-Induced Positive Feedback Loop with PPARδ

  2025cites this paper
• Ursolic Acid from Carissa carandas L. as a Multi-Target Agent Against NSCLC: An Integrative In Silico and In Vitro Study.

  2025cites this paper
• Pharmacological inhibition of Peroxisome Proliferation-Activated Receptor Delta (PPARδ) imparts selective leukemia cell death

  2025cites this paper
• PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer

  2025cites this paper
• Theaflavin inhibits the malignant phenotype of human anaplastic thyroid cancer 8305C cells by regulating lipid metabolism via PI3K/AKT signaling

  2025cites this paper
• Regulatory role of PPAR in colorectal cancer

  2025cites this paper
• DrKGC: Dynamic Subgraph Retrieval-Augmented LLMs for Knowledge Graph Completion across General and Biomedical Domains

  2025cites this paper
• Targeting Peroxisome Proliferator-Activated Receptor-β/δ, Reactive Oxygen Species and Redox Signaling with Phytocompounds for Cancer Therapy

  2024cites this paper
• The Versatile Role of Peroxisome Proliferator-Activated Receptors in Immune-Mediated Intestinal Diseases

  2024cites this paper
• Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of hepatocellular carcinoma (HCC).

  2024cites this paper
• EP4-induced mitochondrial localization and cell migration mediated by CALML6 in human oral squamous cell carcinoma

  2024cites this paper
• Single-cell sequencing revealed metabolic reprogramming and its transcription factor regulatory network in prostate cancer

  2024cites this paper
• Identification of an ADME-related gene for forecasting the prognosis and responding to immunotherapy in sarcomas

  2024cites this paper
• The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy

  2023cites this paper
• Roles of PPAR activation in cancer therapeutic resistance: Implications for combination therapy and drug development.

  2023cites this paper
• Roles of peroxisome proliferator‐activated receptors in hepatocellular carcinoma

  2023cites this paper
• Elafibranor upregulates the EMT-inducer S100A4 via PPARβ/δ.

  2023cites this paper
• Lignin/Puerarin Nanoparticle-Incorporated Hydrogel Improves Angiogenesis through Puerarin-Induced Autophagy Activation

  2023cites this paper
• Long non-coding RNAs CCAT1 and CCAT2 in colorectal liver metastases are tumor-suppressive via MYC interaction and might predict patient outcomes

  2023cites this paper
• Therapeutic Potential of a Small-Molecule STAT3 Inhibitor in a Mouse Model of Colitis

  2023cites this paper
• Pharmacological Utility of PPAR Modulation for Angiogenesis in Cardiovascular Disease

  2023cites this paper
• Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ

  2022cites this paper
• Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors

  2022cites this paper
• Advances in research on the effects of platelet activation in acute lung injury (Review)

  2022cites this paper
• Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway

  2022cites this paper
• Increased PPARD Expression May Play a Protective Role in Human Lung Adenocarcinoma and Squamous Cell Carcinoma

  2022cites this paper
• deepOrganoid: A brightfield cell viability model for screening matrix-embedded organoids.

  2022cites this paper
• Renal Cell Cancer and Obesity

  2022cites this paper
• MrgprF acts as a tumor suppressor in cutaneous melanoma by restraining PI3K/Akt signaling

  2022cites this paper
• Chemical-Empowered Human Adipose-Derived Stem Cells with Lower Immunogenicity and Enhanced Pro-angiogenic Ability Promote Fast Tissue Regeneration

  2022cites this paper
• Differential expression analysis of genes and long non-coding RNAs associated with KRAS mutation in colorectal cancer cells

  2022cites this paper
• Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer

  2022cites this paper
• Synergistic effects of PI3K inhibition and pioglitazone against acute promyelocytic leukemia cells

  2022cites this paper
• Notch signaling pathway: a comprehensive prognostic and gene expression profile analysis in breast cancer

  2022cites this paper
• The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics.

  2021cites this paper
• Identification of Hub Genes Related to Liver Metastasis of Colorectal Cancer by Integrative Analysis

  2021cites this paper
• Identification and Validation of Immune-Related Gene Signature for Predicting Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma

  2021cites this paper
• PPARs and Tumor Microenvironment: The Emerging Roles of the Metabolic Master Regulators in Tumor Stromal–Epithelial Crosstalk and Carcinogenesis

  2021cites this paper
• Diagnostic value of PPARδ and miRNA-17 expression levels in patients with non-small cell lung cancer

  2021cites this paper
• Contribution of RAGE axis activation to the association between metabolic syndrome and cancer

  2021cites this paper
• Cancer-associated fibroblast-derived SDF-1 induces epithelial-mesenchymal transition of lung adenocarcinoma via CXCR4/β-catenin/PPARδ signalling

  2021cites this paper
• PPARs and Angiogenesis—Implications in Pathology

  2020cites this paper
• Development and validation of a hypoxia-related gene signature to predict overall survival in early-stage lung adenocarcinoma patients

  2020cites this paper
• Expression, function and clinical application of stanniocalcin‐1 in cancer

  2020cites this paper
• PPAR Beta/Delta and the Hallmarks of Cancer

  2020cites this paper
• The processes of homeostasis, chemotaxis and organic and inorganic response are significantly up-regulated during short-term oral mucosal cells in vitro cultivation

  2020cites this paper
• Downregulation of the Circadian Rhythm Regulator HLF Promotes Multiple-Organ Distant Metastases in Non-Small Cell Lung Cancer through PPAR/NF-κB Signaling.

  2020cites this paper
• Single-cell transcriptome analysis of the novel coronavirus (SARS-CoV-2) associated gene ACE2 expression in normal and non-obstructive azoospermia (NOA) human male testes

  2020cites this paper
• Nuclear receptors: lipid and hormone sensors with essential roles in the control of cancer development.

  2020cites this paper
• Ppard Is Essential in Acceleration of Pancreatic Ductal Adenocarcinoma Development by High-Fat Diet in Mutant Kras Mice

  2020cites this paper
• The Inhibitory Role of miR-486-5p on CSC Phenotype Has Diagnostic and Prognostic Potential in Colorectal Cancer

  2020influential citation
• The Emerging Role of PPAR Beta/Delta in Tumor Angiogenesis

  2020cites this paper
• Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications

  2020cites this paper
• Suppression of Membranous LRP5 Recycling, Wnt/β-Catenin Signaling, and Colon Carcinogenesis by 15-LOX-1 Peroxidation of Linoleic Acid in PI3P.

  2020influential citation
• ITGB4 is a novel prognostic factor in colon cancer

  2019cites this paper
• PPARdelta mediates the effect of dietary fat in promoting colorectal cancer metastasis.

  2019cites this paper
• PPARD and Interferon Gamma Promote Transformation of Gastric Progenitor Cells and Tumorigenesis in Mice.

  2019cites this paper
• Pleiotropic Effects of PPARD Accelerate Colorectal Tumorigenesis, Progression, and Invasion.

  2019cites this paper
• Aspirin inhibits platelets from reprogramming breast tumor cells and promoting metastasis.

  2019cites this paper
• Aberrant Expression of Peroxisome Proliferator-Activated Receptors in Colorectal Cancer and Their Association with Cancer Progression and Prognosis

  2019cites this paper
• MLL2 promotes cancer cell lymph node metastasis by interacting with RelA and facilitating STC1 transcription.

  2019cites this paper
• Unraveling the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) expression in colon carcinogenesis

  2019cites this paper
• Suppression of membranous LRP5 recycling, WNT/β-catenin signaling, and colorectal tumorigenesis by 15-LOX-1 peroxidation of PI3P_linoleic acid

  2019cites this paper
• DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice

  2018cites this paper
• Pleotropic effects of PPARD accelerate colorectal tumor progression and invasion

  2018cites this paper
• The Lipid Side of Bone Marrow Adipocytes: How Tumor Cells Adapt and Survive in Bone

  2018cites this paper
• The Role of PPARβ/δ in Melanoma Metastasis

  2018cites this paper
• The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor

  2018cites this paper